Human Fetal Liver Cell Transplantation in Chronic Liver Failure

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

April 30, 2011

Study Completion Date

July 31, 2011

Conditions
Liver Cirrhosis
Interventions
OTHER

Human Fetal Liver Cell Transplantation

"Human Fetal Liver Cell Transplantation. Cell source: Non-purified and non-selected fetal liver cells from fetuses aborted between the 16th and 26th week of gestation.~Infusion technique: Isolation and incannulation of the femoral artery.Splenic artery infusion under radiological guidance.~Cell infusion: between 5 and 10x10\^8 cells. Number of sessions: up to 2."

Trial Locations (1)

90127

ISMETT, Palermo

All Listed Sponsors
collaborator

University of Pittsburgh

OTHER

lead

The Mediterranean Institute for Transplantation and Advanced Specialized Therapies

OTHER

NCT01013194 - Human Fetal Liver Cell Transplantation in Chronic Liver Failure | Biotech Hunter | Biotech Hunter